Bekir Cinar, Ph.D.
Affiliations: | 2002 | University of Virginia, Charlottesville, VA |
Area:
Biochemistry, Molecular Biology, Cell Biology, OncologyGoogle:
"Bekir Cinar"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Leland W. K. Chung | grad student | 2002 | UVA | |
| (Regulation of prostate cancer cell growth and prostate specific antigen: Roles of androgen receptor and nuclear factor-kappaB.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Boston AM, Dwead AM, Al-Mathkour MM, et al. (2023) Discordant interactions between YAP1 and polycomb group protein SCML2 determine cell fate. Iscience. 26: 107964 |
| Al-Mathkour MM, Dwead AM, Alp E, et al. (2022) The Hippo effector YAP1/TEAD1 regulates EPHA3 expression to control cell contact and motility. Scientific Reports. 12: 3840 |
| Cinar B, Alp E, Al-Mathkour M, et al. (2021) The Hippo pathway: an emerging role in urologic cancers. American Journal of Clinical and Experimental Urology. 9: 301-317 |
| Cinar B, Al-Mathkour MM, Khan SA, et al. (2020) Androgen attenuates the inactivating phospho-Ser-127 modification of yes-associated protein 1 (YAP1) and promotes YAP1 nuclear abundance and activity. The Journal of Biological Chemistry |
| Pickett IR, Boston AM, Almathkour MM, et al. (2019) Abstract 1022: The role of dopamine signaling in prostate cancer disparities Endocrinology |
| Al-Mathkour MM, Cinar B. (2019) Abstract 2634: The role of Eph A receptor 3 tyrosine kinase signaling in prostate cancer progression Cancer Research. 79: 2634-2634 |
| George A, Raji I, Cinar B, et al. (2018) Design, synthesis, and evaluation of the antiproliferative activity of hydantoin-derived antiandrogen-genistein conjugates. Bioorganic & Medicinal Chemistry |
| Cinar B, Moreno CS. (2018) Abstract 4373: AR signaling in concert with PP2A/B regulates YAP1 expression in prostate cancer cells Cancer Research. 78: 4373-4373 |
| Mohanty SK, Yagiz K, Pradhan D, et al. (2017) STAT3 and STAT5A are potential therapeutic targets in castration-resistant prostate cancer. Oncotarget. 8: 85997-86010 |
| Ready D, Yagiz K, Amin P, et al. (2017) Mapping the STK4/Hippo signaling network in prostate cancer cell. Plos One. 12: e0184590 |